Latest Updates

August 21, 2024

Artificial Intelligence Platforms and Copyright law: is the Legal Belt Tightening?

The U.S. court is hearing artists' lawsuits against AI platforms for copyright infringement. The decision could lead to new regulations and insights into the impact of using protected works for training.

See full article >

January 21, 2024

The Israeli food producer Osem is continuing to transfer intellectual property rights to Nestle

Yuval Lazi and Harel Perlmutter were interviewed by Globes about the transfer of Osem’s intellectual property rights to Nestlé. They explained how this transfer is likely to affect the State of Israel.

See full article >

August 28, 2023

United States: Can AI Systems Hold Copyrights?

Who owns the copyright to an AI-generated image—the creator, the technology, or no one? A recent court ruling in the United States determines that the right to copyright protection depends on the degree of human involvement in the work.

See full article >

January 25, 2023

Determining Intellectual Property Value for Israeli Tax Purposes during a Sale between Related Parties

A sale of intellectual property between related parties requires advance planning and preparation in order to avoid tax exposures in Israel.

See full article >

October 2, 2022

Barnea: Representing Pronto Diagnostics and Owners in Sale to Novolog

Sagi Gross and Dor Levi-Tam represented Pronto Diagnostics and its owners in a transaction to sell control of the company to Novolog. Pronto operates in the field of molecular genetic diagnostics.

See full article >

September 8, 2022

Barnea: Representing Neve Pharma in Sale to Diplomat for NIS 81 Million

Neve Pharma is engaged in the development, marketing, and sale of nutritional supplements, as well as medical accessories in the ENT field. Sixty-five percent of the company was recently sold to the public company Diplomat for NIS 81 million. Neve Pharma was represented by Sagi Gross, Dor Levi-Tam, and Izabel Pashayev in the transaction.

See full article >

May 22, 2022

BioGenCell Completes USD 16 Million Seed Round

Our firm represents BioGenCell, a stem cell research and development company located at Laniado Hospital. The company recently announced the completion of a USD 16 million seed round investment, aided by counsel from Advs. Itay Gura and Inbar Katzir. Our firm has represented the company since its inception.

See full article >

June 21, 2020

Israel Takes US Approach in Enabling Affordable Fast Track to Register Provisional Patents

A new, welcome initiative by the Israel Patent Office intends to allow entrepreneurs, through a preliminary and fast-tracked process, to submit an application for the provisional registration of a patent. This is a significant step, which could revolutionize entrepreneurial innovation in Israel and make it easier on many Israelis who wish to protect future patents. In the course of the fast-track process, the application is not considered for a year, and applicants are able to set an early submission date for the patent's registration.

See full article >

May 5, 2020

Barnea Represents Surf in Sale of Video Division to Lytx

Lytx Inc., an American fleet management software developer, has acquired the video division of the Israel-based company Surf Communications, to serve as its Israeli RD center. Surf, founded in 1996, develops multimedia digital signal processing technologies for telecommunication infrastructures. Firm partners Micky Barnea and Ariella Dreyfuss represented Surf in the deal valued at between $20-30 million.

See full article >

January 8, 2019

Hosting Participants of the EdStart Program

We hosted today participants of AWS EdStart, an educational technology (EdTech) startup accelerator. A number of partners from our firm spoke at the seminar, discussing topics such as founders' agreements, intellectual property, and the tax issues of startups.

October 26, 2018

Year in Review - Technology

In March 2018 the Israel Innovation Authority launched a $264 Million National Digital Health Program, with the aim of promoting Israel as a leader in digital health, and improving the quality and quantity of digital health data to support the research and development of preventive and personalize medicine. The program includes a new National Genomic-Clinical Initiative, aimed at sequencing and analyzing the genomes of 100,000 Israeli volunteers, for the purpose of aiding drug discovery.

See full article >

September 17, 2018

Israel’s Innovation Authority Issues New Know-How Licensing Rules for Multinational Corporations

Israel’s Innovation Authority (the IIA, formerly the Office of the Chief Scientist) has issued new rules regarding the licensing of IIA-funded know-how for use by multinational corporations outside of Israel.

See full article >

September 26, 2017

Article on Regulatory Challenges of FinTech Companies Featured in TheMarker

Micky Barnea, the firm's managing partner,published an article on the regulatory challenges facing Fintech companies, in TheMarker's FinTech Magazine. Micky notes that entry barriers to this field are not only the development stage, but also the strength of the regulatory solution. Therefore, acquired knowledge can become a real intellectual property and carry enormous potential.

View PDF >

Search by Practice

Latest Updates / IP and Licensing